home / stock / aura / aura quote
Last: | $7.01 |
---|---|
Change Percent: | -0.43% |
Open: | $6.93 |
Close: | $7.01 |
High: | $7.08 |
Low: | $6.8 |
Volume: | 129,736 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$7.01 | $6.93 | $7.01 | $7.08 | $6.8 | 129,736 | 07-05-2024 |
$6.9 | $7.18 | $6.9 | $7.18 | $6.9 | 209,347 | 07-04-2024 |
$6.9 | $7.18 | $6.9 | $7.18 | $6.9 | 209,347 | 07-03-2024 |
$7.15 | $7.32 | $7.15 | $7.375 | $7.15 | 70,885 | 07-02-2024 |
$7.37 | $7.57 | $7.37 | $7.79 | $7.31 | 116,841 | 07-01-2024 |
$7.56 | $7.35 | $7.56 | $7.58 | $7.25 | 1,655,056 | 06-28-2024 |
$7.28 | $7.18 | $7.28 | $7.33 | $7.08 | 169,362 | 06-27-2024 |
$7.13 | $6.84 | $7.13 | $7.16 | $6.63 | 174,188 | 06-26-2024 |
$6.81 | $7.21 | $6.81 | $7.21 | $6.77 | 137,851 | 06-25-2024 |
$7.11 | $7.31 | $7.11 | $7.42 | $7.1 | 100,466 | 06-24-2024 |
$7.2 | $6.93 | $7.2 | $7.25 | $6.91 | 137,223 | 06-21-2024 |
$6.93 | $7.07 | $6.93 | $7.28 | $6.85 | 194,110 | 06-20-2024 |
$7.05 | $7.45 | $7.05 | $7.54 | $7.03 | 139,495 | 06-19-2024 |
$7.05 | $7.45 | $7.05 | $7.54 | $7.03 | 139,495 | 06-18-2024 |
$7.4 | $7.21 | $7.4 | $7.46 | $7.1 | 202,435 | 06-17-2024 |
$7.33 | $7.06 | $7.33 | $7.38 | $6.95 | 88,484 | 06-14-2024 |
$7.2 | $7.25 | $7.2 | $7.46 | $7.13 | 78,606 | 06-13-2024 |
$7.24 | $7.39 | $7.24 | $7.54 | $7.2 | 121,311 | 06-12-2024 |
$7.14 | $7.16 | $7.14 | $7.225 | $6.96 | 123,523 | 06-11-2024 |
$7.24 | $7.46 | $7.24 | $7.578 | $6.995 | 127,517 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Aura Biosciences Inc. Company Name:
AURA Stock Symbol:
NASDAQ Market:
Aura Biosciences Inc. Website:
(NewsDirect) Aura Energy Ltd (ASX:AEE, AIM:AURA) MD Dave Woodall speaks with Proactive soon after announcing the company has raised A$10 million via a share placement at A$0.185 per share to advance development across the company’s project portfolio. The placement was supported by exis...
(NewsDirect) Aura Energy Limited (ASX: AEE, AIM: AURA) CEO Dave Woodall responds to a recent report that the Industry Committee of the Swedish parliament has voted to reject a number of private members’ motions supporting an immediate lifting of the ban on uranium mining in Sweden. He ...
U.S. Food and Drug Administration (FDA) Grants Fast Track Designation for Belzupacap Sarotalocan (bel-sar) for the Treatment of Choroidal Metastasis, Bel-sar’s Second Ocular Oncology Indication to Receive this Designation Global Phase 3 Trial in Primary Choroidal Melanoma on Track ...